Austrian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 21 - 40 out of 155 displayed.
« 1 2 3 4 5 6 7 8 »

Novo Nordisk A/S – Reduction of the share capital

Read more ››

By: GlobenewsWire - 27 Apr 2021

Novo Nordisk A/S - Articles of Association

Read more ››

By: GlobenewsWire - 27 Apr 2021

Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17 to treat Huntington’s disease to be presented at the 16th Annual Huntington's Disease Therapeutics Conference

Read more ››

By: GlobenewsWire - 27 Apr 2021

Related companies: AFFiRiS AG

Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial

Read more ››

By: GlobenewsWire - 26 Apr 2021

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 26 Apr 2021

New Dupixent® (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years

Read more ››

By: GlobenewsWire - 23 Apr 2021

Valneva Initiates Phase 3 Clinical Trial for its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001

Read more ››

By: GlobenewsWire - 21 Apr 2021

Novo Nordisk to initiate phase 3a development in obesity with oral semaglutide

Read more ››

By: GlobenewsWire - 21 Apr 2021

Statement on Issuance of Form FDA 483 at Emergent Bayview Facility

Read more ››

By: GlobenewsWire - 21 Apr 2021

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Valneva Switches Focus to Bilateral Discussions to Supply its Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001

Read more ››

By: GlobenewsWire - 20 Apr 2021

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 19 Apr 2021

European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma

Read more ››

By: GlobenewsWire - 19 Apr 2021

GT Apeiron Therapeutics Strengthens Advisory Board

Read more ››

By: PR Newswire Association LLC. - 16 Apr 2021

Emergent BioSolutions to Release First Quarter 2021 Financial Results and Conduct a Conference Call on April 29, 2021

Read more ››

By: GlobenewsWire - 15 Apr 2021

Related companies: Emergent BioSolutions Inc. | Erste Group Bank AG

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 12 Apr 2021

Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and Initiates Antibody Persistence Trial

Read more ››

By: GlobenewsWire - 12 Apr 2021

Sanofi to invest in a leading-edge production site in Singapore; continues to strengthen its vaccines manufacturing capacities

Read more ››

By: GlobenewsWire - 12 Apr 2021

Valneva Files Registration Statement for Proposed United States Initial Public Offering

Read more ››

By: GlobenewsWire - 10 Apr 2021

Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates

Read more ››

By: GlobenewsWire - 10 Apr 2021

Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas

Read more ››

By: GlobenewsWire - 09 Apr 2021

« 1 2 3 4 5 6 7 8 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

May 2021
- European Health-tech Innovation Week
- 7th Annual Immuno-Oncology Innovation Forum
- Pharma-Biotech Product & Company Valuation Course

Add an Event »

Latest company news

Qu Biologics Files Important New IP for the Treatment of Post-Surgical Immune Dysfunction and Prevention of Cancer Metastasis
12 May 2021 (GlobenewsWire)

Valneva Announces Closing of $107.6 million Global Offering
11 May 2021 (GlobenewsWire)

Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million
10 May 2021 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Austrian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com